Medical Devices

  • Zimmer Biomet's Rosa robotic surgery system.
    Image attribution tooltip
    Permission granted by Zimmer Biomet
    Image attribution tooltip

    Zimmer hires chief science, technology and medical affairs officer

    Jonathan Vigdorchik, an orthopedic surgeon from the Hospital for Special Surgery, previously was chief medical technology adviser for the company.

    By • April 7, 2026
  • A picture of a blue pulsed field ablation catheter against a gray background.
    Image attribution tooltip
    Courtesy of Johnson & Johnson MedTech
    Image attribution tooltip

    J&J launches enhanced PFA device in Europe

    The Varipulse Pro pulsed field ablation platform, which has received a CE mark, will be a focus at the upcoming European Heart Rhythm Association annual meeting in Paris.

    By • April 7, 2026
  • Intuitive Surgical's da Vinci 5 robotic system. Explore the Trendline➔
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • A skyline shot of a large city, bifurcated by a large river.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    UK steps up push to align medtech regulations with the US

    Health regulators on both sides of the Atlantic are assessing alignment opportunities and exploring mutual recognition mechanisms.

    By • April 7, 2026
  • FDA
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    VDyne secures FDA nod to start pivotal trial for tricuspid valve

    With approval to study the transcatheter replacement device in patients with severe tricuspid regurgitation, VDyne is advancing a treatment to compete with Edwards Lifesciences’ Evoque system.

    By • April 6, 2026
  • Professional photo of Steve MacMillan
    Image attribution tooltip
    Retrieved from Hologic on April 06, 2026
    Image attribution tooltip

    Hologic CEO Steve MacMillan to retire after go-private deal

    The $18.3 billion acquisition by Blackstone and TPG is expected to close Tuesday. 

    By • April 6, 2026
  • Boston Scientific's headquarters building is shown.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific closes buyout of Valencia Technologies

    The deal positions Boston Scientific to compete with Medtronic for a market that analysts believe is highly under-penetrated.

    By • April 6, 2026
  • Entrance to a neoclassical building facade that reads "Environmental Protection Agency. "
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Scientists urge EPA not to weaken ethylene oxide emissions standards

    Scientists, clinicians and residents of communities near medical device sterilization plants called for the EPA not to weaken its oversight of ethylene oxide in a public hearing.

    By • April 3, 2026
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Restore Robotics cleared to remanufacture 2 more da Vinci Xi instruments

    The remanufacturer said it now has a total of four clearances for Intuitive Surgical da Vinci instruments from the Food and Drug Administration.

    By • April 3, 2026
  • Kiromic cancer tumors cells
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Merit Medical acquires View Point for $140M

    View Point sells tumor tissue localization devices that could complement Merit’s existing presence in the sector.

    By • April 2, 2026
  • Johnson & Johnson's Impella CP heart pump is shown in an illustration of the heart.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J’s Impella heart pump shows no patient benefit in 2 trials

    Study investigators cautioned against routine use of the device in complex percutaneous coronary interventions and to treat heart attack patients who don’t have cardiogenic shock.

    By • April 1, 2026
  • A stylized collage centers on a handheld medical device resembling a glucose monitor, overlaid on bold red and blue geometric shapes, with faint overhead images of empty office desks in the background and the word “REJECTED” repeated in gray text.
    Image attribution tooltip

    Photo illustration: Mark Harris

    Image attribution tooltip
    Deep Dive

    ‘Cracks show’ as CDRH staff contend with heavy workloads

    Former device leaders said a culture of “fear and anxiety” has driven experienced staff from the Food and Drug Administration. An overburdened workforce has affected communications from the agency.

    By , • April 1, 2026
  • Two clinicians operate Distalmotion's Dexter robotic system in an operating room.
    Image attribution tooltip
    Permission granted by Distalmotion
    Image attribution tooltip

    Distalmotion targets ASC robotic gynecology programs with FDA filing

    The company is seeking clearance in additional gynecological indications to support outpatient use of its surgical robot.

    By • April 1, 2026
  • A person hits a soccer ball with their head while wearing a wristband.
    Image attribution tooltip
    Courtesy of Whoop
    Image attribution tooltip

    Whoop raises $575M, adds Abbott as strategic investor

    Whoop, the maker of a wearable wristband, plans to use the funds for global expansion and personalized health features.

    By • March 31, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic wins CE mark for OmniaSecure defibrillation lead

    The device maker designed the lead to have the safety benefits of small-diameter devices without sacrificing durability.

    By • March 31, 2026
  • Medtronic's Symplicity Spyral device is shown against a white background.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic to study renal denervation combined with PCI

    Medtronic detailed plans to further study the blood pressure treatment while releasing additional data from the SPYRAL HTN trials that showed the procedure reduced hypertensive emergencies.

    By • March 31, 2026
  • A rendering of a rounded device with a wire structure surrounded by mesh.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific posts positive stroke prevention data for Watchman

    The company said it will seek an expanded indication for the left atrial appendage closure device after it met all safety and efficacy goals in the closely watched CHAMPION-AF study.

    By • March 30, 2026
  • Medtronic's Stealth AXiS system.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic wins FDA clearance for robot in cranial, ENT surgeries

    The surgical navigation and robotics system is part of the company’s push to expand its share of the $15 billion cranial and spinal technologies market.

    By • March 30, 2026
  • A rectangular, metallic device on a catheter sites next to three nickels.
    Image attribution tooltip
    Permission granted by Glucotrack
    Image attribution tooltip

    Glucotrack plans US trial of implantable glucose monitor this year

    Glucotrack plans to file for an investigational device exemption in the second quarter, with hopes of starting a trial in the second half of 2026.

    By • March 27, 2026
  • A physician in blue scrubs and a mask looks at Philips' DeviceGuide images on a large screen.
    Image attribution tooltip
    Courtesy of Philips
    Image attribution tooltip

    Philips wins FDA clearance for imaging device developed with Edwards

    The system uses AI to optimize the placement of Edwards’ mitral valve repair device.

    By • March 27, 2026
  • Silhouette of stressed businesswoman in the office.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Endologix to close production facility, lay off 31 people

    The company acquired the facility in the PQ Bypass takeover it struck in the aftermath of its bankruptcy filing.

    By • March 26, 2026
  • The Strait of Hormuz shown by a satellite image in 2020, with the Persian Gulf and Gulf of Oman on each side.
    Image attribution tooltip
    Retrieved from NASA's Moderate Resolution Imaging Spectroradiometer.
    Image attribution tooltip

    Manufacturers brace for price increases from Strait of Hormuz closure

    Crude oil prices have surged 47% this month and polypropylene jumped 24%, affecting transportation and plastics costs.

    By Nathan Owens • March 26, 2026
  • CMR Surgical's Versius Plus robotic system is shown in blue lighting.
    Image attribution tooltip
    Permission granted by CMR Surgical
    Image attribution tooltip

    CMR Surgical robot builds momentum ahead of US rollout

    CMR Surgical is formally introducing its Versius robot at a surgeons’ meeting this week in what CEO Massimiliano Colella described as a “watershed moment” for the company.

    By • March 26, 2026
  • The SS Innovations SSi Mantra robotic system.
    Image attribution tooltip
    Permission granted by SS Innovations
    Image attribution tooltip

    Meet 6 medtech companies redefining surgical robotics

    Executives at companies innovating a range of new robotic surgery platforms shared their progress and challenges in MedTech Dive's series of profiles.

    By • Updated March 25, 2026
  • A person sits at a table with food, wearing a pink, rectangular device attached to a striped dress.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    Medtronic lowers earnings forecast after MiniMed IPO

    The timing of the initial public offering and the clearance of a new insulin pump are expected to affect Medtronic’s results for its 2026 fiscal year.

    By • March 25, 2026
  • An illustration of the Medtronic OmniaSecure defibrillation lead in the heart.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic’s OmniaSecure defibrillation lead earns expanded FDA indication

    The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate the natural electrical system.

    By • March 25, 2026